Delivery Order SPE2DB24D2205-SPE2DB24FDUSX
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,927.98 firm fixed price delivery order is for the supply of 4565933394 dexmethylphenidate extended-release capsules, 5 milligrams. This award is not associated with a set-aside program and has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,306.89 Delivery Order is for the supply of 4564327550 - DEXTROAMP-AMPHET ER 10 MG CAP 100S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of the major pharmaceutical distributor Amerisourcebergen Corporation. The $2,344.44 firm fixed price delivery order is for the supply of dexmethylphenidate extended-release capsules, a prescription medication, to government facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order valued at $50,133.85 for the supply of pharmaceutical products and medical supplies to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has no set-aside designation and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,338.15 firm-fixed-price delivery order is for the supply of 4,565,191,653 units of 5 mg Dextromethylphenidate Extended-Release capsules. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, holding several Indefinite...
- This federal contract award was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,150.64 Firm Fixed Price Delivery Order is for the supply of 4564740104 - Dexmethylphenidate ER Capsules 25mg. The award has an Ultimate Completion Date of May 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,018.24 Firm Fixed Price Delivery Order is for the provision of pharmaceutical products and medical supplies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $23,364.44 firm fixed-price delivery order is for the provision of pharmaceutical products and medical supplies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,286.48 firm fixed-price delivery order is for the supply of 4,564,377,306 methylphenidate extended-release 36mg tablets, with a performance period through April 24, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract valued at $12,618.62 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a completion date of June 18, 2024, is for the provision of pharmaceutical products and medical supplies to support the Department of Defense and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDUSXDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,063.28 firm fixed price delivery order is for the supply of 4564740880 dexmethylphenidate extended-release 10 mg capsules. The contract has a completion date of May 30, 2024 and does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/29/24 |